| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ACE inhibitors in the management of congestive heart failure: Comparative economic data
|
Boyko Jr., William L.
|
|
1999
|
137 |
5 |
p. S115-S119
5 p.
|
artikel
|
| 2 |
Angiotensin-converting enzyme inhibitors in the management of congestive heart failure: A pharmaceutical industry perspective
|
Boccuzzi, Stephen J.
|
|
1999
|
137 |
5 |
p. S120-S122
3 p.
|
artikel
|
| 3 |
An industry perspective on health economics studies
|
Anderson, Keaven M.
|
|
1999
|
137 |
5 |
p. S129-S132
4 p.
|
artikel
|
| 4 |
Antianginal efficacy of the combination of felodipine-metoprolol 10/100 mg compared with each drug alone in patients with stable effort-induced angina pectoris: A multicenter parallel group study
|
Emanuelsson, Håkan
|
|
1999
|
137 |
5 |
p. 854-862
9 p.
|
artikel
|
| 5 |
Association of left ventricular dilatation and hypertrophy with chronotropic incompetence in the Framingham Heart Study
|
Lauer, Michael S.
|
|
1999
|
137 |
5 |
p. 903-909
7 p.
|
artikel
|
| 6 |
A survey of standards and guidelines for cost-effectiveness analysis in health care*
|
Stewart, Alan
|
|
1999
|
137 |
5 |
p. S53-S61
9 p.
|
artikel
|
| 7 |
Cardioprotection for Duchenne’s muscular dystrophy
|
Ishikawa, Yuka
|
|
1999
|
137 |
5 |
p. 895-902
8 p.
|
artikel
|
| 8 |
Clinical significance of syncope in the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) trial
|
Olshansky, Brian
|
|
1999
|
137 |
5 |
p. 878-886
9 p.
|
artikel
|
| 9 |
Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus
|
Kang, Xingping
|
|
1999
|
137 |
5 |
p. 949-957
9 p.
|
artikel
|
| 10 |
Comparative economic data regarding lipid-lowering drugs
|
Schwartz, J.Sanford
|
|
1999
|
137 |
5 |
p. S97-S104
8 p.
|
artikel
|
| 11 |
Congestive heart failure hospitalizations and survival in California: Patterns according to race/ethnicity
|
Alexander, Mark
|
|
1999
|
137 |
5 |
p. 919-927
9 p.
|
artikel
|
| 12 |
Consortium perspective: What constitutes a useful economic study?
|
Chen, Connie
|
|
1999
|
137 |
5 |
p. S71-S74
4 p.
|
artikel
|
| 13 |
Coronary artery calcification: “...empty your cup...”
|
Rumberger, John A.
|
|
1999
|
137 |
5 |
p. 774-776
3 p.
|
artikel
|
| 14 |
Coronary calcium: The good, the bad, and the uncertain
|
Doherty, Terence M.
|
|
1999
|
137 |
5 |
p. 806-814
9 p.
|
artikel
|
| 15 |
Coronary stents: A health system perspective
|
Ahmad, Muzaffar
|
|
1999
|
137 |
5 |
p. S142-S144
3 p.
|
artikel
|
| 16 |
Coronary stents: An industry perspective
|
Marshall, Paul R.
|
|
1999
|
137 |
5 |
p. S138-S141
4 p.
|
artikel
|
| 17 |
Dealing with success at the American Heart Journal
|
Califf, Robert M.
|
|
1999
|
137 |
5 |
p. 769-
1 p.
|
artikel
|
| 18 |
Determinants of aortic artifacts during transesophageal echocardiography of the ascending aorta
|
Losi, Maria Angela
|
|
1999
|
137 |
5 |
p. 967-972
6 p.
|
artikel
|
| 19 |
Diastolic dysfunction: Old dog, new tricks
|
Douglas, Pamela S.
|
|
1999
|
137 |
5 |
p. 777-778
2 p.
|
artikel
|
| 20 |
Disparate effects of the 1989 Loma Prieta and 1994 Northridge earthquakes on hospital admissions for acute myocardial infarction: Importance of superimposition of triggers
|
Brown, David L.
|
|
1999
|
137 |
5 |
p. 830-836
7 p.
|
artikel
|
| 21 |
Early referral for intentional rescue PTCA after initiation of thrombolytic therapy in patients admitted to a community hospital because of a large acute myocardial infarction
|
Oude Ophuis, Ton J.M.
|
|
1999
|
137 |
5 |
p. 846-853
8 p.
|
artikel
|
| 22 |
Echocardiographic evaluation of patients with primary antiphospholipid syndrome
|
Espínola-Zavaleta, Nilda
|
|
1999
|
137 |
5 |
p. 973-978
6 p.
|
artikel
|
| 23 |
Economics and cost-effectiveness in evaluating the value of cardiovascular therapies: A health system perspective on thrombolytic therapy for acute myocardial infarction
|
Lewandowski, Christopher A.
|
|
1999
|
137 |
5 |
p. S94-S96
3 p.
|
artikel
|
| 24 |
Economics and cost-effectiveness in evaluating the value of cardiovascular therapy: Lipid-lowering therapies — an industry perspective
|
Jackson, Joseph D.
|
|
1999
|
137 |
5 |
p. S105-S110
6 p.
|
artikel
|
| 25 |
Effect of intravenous metoprolol before hospital admission on chest pain in suspected acute myocardial infarction
|
Gardtman, Marie
|
|
1999
|
137 |
5 |
p. 821-829
9 p.
|
artikel
|
| 26 |
Elevated cardiac troponin I predicts a high-risk angiographic anatomy of the culprit lesion in unstable angina
|
Benamer, Hakim
|
|
1999
|
137 |
5 |
p. 815-820
6 p.
|
artikel
|
| 27 |
Evaluating the economic implications of cardiovascular therapeutics
|
Califf, Robert M.
|
|
1999
|
137 |
5 |
p. S35-S37
3 p.
|
artikel
|
| 28 |
Evaluation of the cost-effectiveness of coronary stenting: A societal perspective
|
Cohen, David J.
|
|
1999
|
137 |
5 |
p. S133-S137
5 p.
|
artikel
|
| 29 |
Fundamentals of economic analysis
|
Mark, Daniel B.
|
|
1999
|
137 |
5 |
p. S38-S40
3 p.
|
artikel
|
| 30 |
Health system perspective regarding glycoprotein IIb/IIIa inhibitor therapy
|
Schrogie, John J.
|
|
1999
|
137 |
5 |
p. S126-S128
3 p.
|
artikel
|
| 31 |
High-dose enoximone to evaluate reversibility of pulmonary hypertension: Is there a diagnostic value of neurohormonal measurements?
|
Schulz, Olaf
|
|
1999
|
137 |
5 |
p. 887-894
8 p.
|
artikel
|
| 32 |
How generalizable are coronary risk prediction models? Comparison of Framingham and two national cohorts
|
Liao, Youlian
|
|
1999
|
137 |
5 |
p. 837-845
9 p.
|
artikel
|
| 33 |
Lipid-lowering drugs, cost-effectiveness data, and the formulary system: A health systems perspective
|
Kessler, John M.
|
|
1999
|
137 |
5 |
p. S111-S114
4 p.
|
artikel
|
| 34 |
Longitudinal changes and prognostic implications of left ventricular diastolic function in first acute myocardial infarction
|
Poulsen, Steen H.
|
|
1999
|
137 |
5 |
p. 910-918
9 p.
|
artikel
|
| 35 |
Lung thallium imaging in coronary transplant arteriopathy: “Ce n’est pas un pipe”
|
Miller, D.Douglas
|
|
1999
|
137 |
5 |
p. 782-785
4 p.
|
artikel
|
| 36 |
Multicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction
|
Sadowski, Zygmunt P.
|
|
1999
|
137 |
5 |
p. 792-798
7 p.
|
artikel
|
| 37 |
Natural disaster plus wake-up time: A deadly combination of triggers
|
Kloner, Robert A.
|
|
1999
|
137 |
5 |
p. 779-781
3 p.
|
artikel
|
| 38 |
[No title]
|
|
|
1999
|
137 |
5 |
p. 5A-
1 p.
|
artikel
|
| 39 |
Prediction of human transplantation arteriopathy and coronary events with lung/heart count ratios during intravenous dipyridamole thallium-201 imaging
|
Lenihan, Daniel J.
|
|
1999
|
137 |
5 |
p. 942-948
7 p.
|
artikel
|
| 40 |
Product labeling and pharmacoeconomic information
|
Morris, Louis A.
|
|
1999
|
137 |
5 |
p. S78-S80
3 p.
|
artikel
|
| 41 |
Prophylactic lidocaine use in acute myocardial infarction: Incidence and outcomes from two international trials
|
Alexander, John H.
|
|
1999
|
137 |
5 |
p. 799-805
7 p.
|
artikel
|
| 42 |
Prophylactic lidocaine use in acute myocardial infarction revisited in the thrombolytic era
|
Tan, Hanno L.
|
|
1999
|
137 |
5 |
p. 770-773
4 p.
|
artikel
|
| 43 |
Rationale and design of the Prospective Army Coronary Calcium (PACC) Study: Utility of electron beam computed tomography as a screening test for coronary artery disease and as an intervention for risk factor modification among young, asymptomatic, active-duty United States Army personnel
|
O’Malley, Patrick G.
|
|
1999
|
137 |
5 |
p. 932-941
10 p.
|
artikel
|
| 44 |
Real-time, three-dimensional echocardiography: Feasibility of dynamic right ventricular volume measurement with saline contrast
|
Ota, Takahiro
|
|
1999
|
137 |
5 |
p. 958-966
9 p.
|
artikel
|
| 45 |
Recovery rates of regional sympathetic reinnervation and myocardial blood flow after acute myocardial infarction
|
Fallen, Ernest L.
|
|
1999
|
137 |
5 |
p. 863-869
7 p.
|
artikel
|
| 46 |
Relation of salivary cotinine to blood pressure in middle-aged cigarette smokers
|
Istvan, Joseph A.
|
|
1999
|
137 |
5 |
p. 928-931
4 p.
|
artikel
|
| 47 |
Role of economic models in randomized clinical trials
|
Hlatky, Mark A.
|
|
1999
|
137 |
5 |
p. S41-S46
6 p.
|
artikel
|
| 48 |
Role of government agencies regarding cost-effectiveness claims: FDA perspective
|
Temple, Robert
|
|
1999
|
137 |
5 |
p. S75-S77
3 p.
|
artikel
|
| 49 |
Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: The ASSENT-1 trial
|
Van de Werf, Frans
|
|
1999
|
137 |
5 |
p. 786-791
6 p.
|
artikel
|
| 50 |
Statistical issues in cost-effectiveness analysis
|
DeLong, Elizabeth R.
|
|
1999
|
137 |
5 |
p. S47-S50
4 p.
|
artikel
|
| 51 |
Terminology I would like to see disappear
|
Detsky, Allan S.
|
|
1999
|
137 |
5 |
p. S51-S52
2 p.
|
artikel
|
| 52 |
The high cost of syncope: Cost implications of a new insertable loop recorder in the investigation of recurrent syncope
|
Krahn, Andrew D.
|
|
1999
|
137 |
5 |
p. 870-877
8 p.
|
artikel
|
| 53 |
The impact of the cost-effectiveness study of GUSTO-1 on decision making with regard to fibrinolytic therapy
|
Califf, Robert M.
|
|
1999
|
137 |
5 |
p. S90-S93
4 p.
|
artikel
|
| 54 |
The value of cost-effectiveness analyses for reimbursement decisions: Perspectives from Medicare
|
Sheingold, Steven H.
|
|
1999
|
137 |
5 |
p. S81-S86
6 p.
|
artikel
|
| 55 |
Thrombolytic therapy: Economic considerations
|
Krumholz, Harlan M.
|
|
1999
|
137 |
5 |
p. S87-S89
3 p.
|
artikel
|
| 56 |
Use of abciximab: Comparative economic data
|
Mark, Daniel B.
|
|
1999
|
137 |
5 |
p. S123-S125
3 p.
|
artikel
|
| 57 |
What constitutes a useful economic study? The health systems perspective
|
Lee, Thomas H.
|
|
1999
|
137 |
5 |
p. S67-S70
4 p.
|
artikel
|
| 58 |
What constitutes a useful health economic study for the pharmaceutical industry?
|
Gagnon, Jean Paul
|
|
1999
|
137 |
5 |
p. S62-S66
5 p.
|
artikel
|
Tijdschrift beschrijving